Cation Contributions To Potentiometric Dye Responses In Human Platelets

1981 ◽  
Author(s):  
Jonathan L Miller ◽  
Theodore M Mazer

The potentiometric dye, Di-S-C3(5) (0.9μM) was incubated with stirred suspensions of-3washed human platelets (5-6 × 104μl) in buffer containing 137mM NaCl, 2.7mM KCl, 0.2% dextrose, and 25mM Tris-HCl, pH 7.4 in an Ami neo-Bowman fluorometer, with excitation λ 620nm and emmision λ 680nm. Equilibrium levels of fluorescence (F) nearly doubled as external potassium concentration (K °) was increased from 2.7mM to 105.6mM. Addition of°2mM CaCl2 always produced immediate transient increases in F, regardless of K0 , in contrast to the increases or decreases produced by the potassium ionophore, valino- mycin (VAL) (5μM) in adherance to the electrochemical gradient determined by the choice of K°. Equilibrium F was also relatively insensitive to external calcium (Ca°) at either high or low levels of K . However, add?tion of the calcium ionophore, A23187 (10μM) produced immediate increases in F, with peak values (F-A23peak) increasing sharply with increasing Ca°. At a given Ca the F-A23peak was insensitve to K ° however, with the prior addition of VAL, F-A23peak became sensitive to K , particularly so at the lowest values of K° , where the F-A23peak was significantly lower in tne presence than in the absence of VAL. Replacement of sodium by choline had no significant effect on equilibrium F or on responses to VAL or to A23187- Platelet agglutination induced by ristocetin plus cryoprecipitate was not accompanied by similar increases in F.These findings suggest that Di – S–C3 F reflects a strong contribution of potassium permeability in the resting state, with relatively little contribution by calcium. Production of an activated state in platelets by A23187, in contrast, results in an increase in F that appears to reflect a major contribution by calcium.

1996 ◽  
Vol 76 (03) ◽  
pp. 439-443 ◽  
Author(s):  
Masaru Ido ◽  
Shinya Kato ◽  
Hiroyuki Ogawa ◽  
Kenji Hayashi ◽  
Yoshihiro Komada ◽  
...  

SummaryThrombin stimulation induces a dramatic increase in the activity of the 33-kDa serine/threonine kinase (PK33) in human platelets (10). The Arg-Gly-Asp (RGD) peptide, an inhibitor of the thrombin-mediated aggregation of platelets, did not affect the PK33 activation induced by thrombin suggesting that the activation of this kinase occurs independently from platelet aggregation. To identify a potential role of Ca2+ and calmodulin in the regulation of PK33, the effect of several Ca2+/calmodulin inhibitors on the thrombin-induced activation of PK33 was assessed using denaturation/renaturation method. Pretreatment of platelets with EGTA decreased the maximum PK33 activity induced by thrombin. The chelation of both the extra- and the intracellular Ca2+ by EGTA and by acetoxymethyl ester of 5,5′ -dimethyl-bis-(<9-aminophen-oxy) ethane-N,N,N′,N′-tetraacetic acid (BAPTA-AM) decreased further the PK33 activation by thrombin. Preincubation of platelets with the anticalmodulin agent, N-(4-aminobutyl)-5-chloro-2-naphtha-lenesulfonamide (W13), inhibited markedly the activation of PK33 by thrombin, whereas the inactive structural analog N-(4-aminobutyl)-2-naphthalenesulfonamide (W12) and the myosin light chain kinase inhibitor 1 -(5-chloronaphthalene-1 -sulfonyl)-1 H-hexahydro-1,4-diaze-pine (ML9) showed very weak inhibitory effects. Treatment of resting platelets with the calcium ionophore, A23187, activated PK33 in a dose-dependent manner; phorbol 12-myristate 13-acetate enhanced this effect. However, the two foregoing agents did not induce similar degree of PK33 activities as thrombin. These results indicate that the activation of PK33 is independent of the formation of the GPIIb/IIIa-fibrinogen complex and that it might be regulated by a Ca2+-dependent pathway.


Blood ◽  
1991 ◽  
Vol 77 (5) ◽  
pp. 996-1005 ◽  
Author(s):  
H Lu ◽  
C Soria ◽  
EM Cramer ◽  
J Soria ◽  
J Maclouf ◽  
...  

Abstract It is known that at 37 degrees C plasmin may have two opposite effects on platelets: at high concentrations (greater than 1.5 caseinolytic units [CU]/mL), plasmin activates platelets; at lower concentrations (0.1 to 1.0 CU/mL) it inhibits platelet activation induced by thrombin, collagen, or calcium ionophore A23187. In this study, we report that when lowering the incubation temperature to 22 degrees C, plasmin at low concentrations (0.1 to 0.5 CU/mL) fully activated platelets. When platelets were treated with 0.2 CU/mL of plasmin, lowering the incubation temperature from 37 degrees C to 22 degrees C resulted in an increase in the expression of fibrinogen receptors, in platelet release and aggregation. Thromboxane A2 was not generated by plasmin treatment at either temperature. Ultrastructural studies showed that platelets responded to low-dose plasmin at 37 degrees C by forming pseudopods, centralizing granules without fibrinogen release, whereas at 22 degrees C the same dose of plasmin caused platelet degranulation with the appearance of alpha-granule fibrinogen within the lumen of the surface connected canalicular system. In addition, at 22 degrees C plasmin at doses insufficient to induce platelet aggregation potentiated platelet response to thrombin. Thus, we suggest that plasmin may initiate both activating and inhibitory processes within platelets and that the change of temperature could influence this balance. These results may be of clinical relevance, because the fibrinolytic system was found activated during cardiopulmonary bypass in which the temperature of patient's blood circulation was reduced. This temperature-dependent behavior is also an interesting model for a further study on platelet response to serine proteinases.


Blood ◽  
1979 ◽  
Vol 53 (3) ◽  
pp. 437-445 ◽  
Author(s):  
DF Mosher ◽  
A Vaheri ◽  
JJ Choate ◽  
CG Gahmberg

Abstract We labeled surface glycoproteins of human platelets by the neuraminidase-galactose oxidase/borotritiide and the periodate/borotritiide methods. When labeled platelets were treated with 1-nM thrombin, a minor glycoprotein weighing 68,000–85,000-d was lost from the surface, and a soluble glycoprotein weighing 57,000- 68,000-d was found in the supernatant. Treatment of platelets with ADP, collagen, or the calcium ionophore A23187 did not cause loss of the 68,000–85,000-d glycoprotein from platelet surfaces or appearance of the 57,000–68,000-d glycoprotein in the supernatant. However, trace amounts of the intact 68,000–85,000-d glycoprotein were found in the supernatants of platelets that were not treated with thrombin. The numerous effects of thrombin on platelets could be initiated by cleavage and release the thrombin-sensitive glycoprotein.


Blood ◽  
1988 ◽  
Vol 72 (6) ◽  
pp. 2020-2025 ◽  
Author(s):  
WF Novotny ◽  
TJ Girard ◽  
JP Miletich ◽  
GJ Jr Broze

Stimulation with thrombin or the calcium ionophore, A23187 caused human platelets to release a coagulation inhibitor similar to the Lipoprotein Associated Coagulation Inhibitor (LACI). This was documented functionally, with clotting assays measuring tissue factor inhibition and factor Xa inhibition, as well as immunologically, in a competitive immunoassay. The total amount of LACI released by 3 x 10(8) platelets after two hours stimulation was 7% to 8% of the amount found in 1 mL of serum. Half of the LACI was released by five minutes. The LACI was present in the platelet supernatant and was not associated with the platelet membrane or shed vesicles. The tissue factor and factor Xa inhibitory activities that were released were neutralized by preincubating the platelet supernatants with specific rabbit polyclonal anti-LACI IgG. On Western blot, platelet LACI appeared to run as a doublet with a molecular weight (mol wt) 45,000 to 47,000. Blood samples obtained from the site of a wound (template bleeding time) demonstrated a progressive increase in LACI concentration. A cDNA probe, derived from endothelial cell LACI cDNA, hybridized selectively to 4.0 and 1.4 kb transcripts in a preparation of platelet mRNA.


Blood ◽  
1991 ◽  
Vol 77 (5) ◽  
pp. 996-1005
Author(s):  
H Lu ◽  
C Soria ◽  
EM Cramer ◽  
J Soria ◽  
J Maclouf ◽  
...  

It is known that at 37 degrees C plasmin may have two opposite effects on platelets: at high concentrations (greater than 1.5 caseinolytic units [CU]/mL), plasmin activates platelets; at lower concentrations (0.1 to 1.0 CU/mL) it inhibits platelet activation induced by thrombin, collagen, or calcium ionophore A23187. In this study, we report that when lowering the incubation temperature to 22 degrees C, plasmin at low concentrations (0.1 to 0.5 CU/mL) fully activated platelets. When platelets were treated with 0.2 CU/mL of plasmin, lowering the incubation temperature from 37 degrees C to 22 degrees C resulted in an increase in the expression of fibrinogen receptors, in platelet release and aggregation. Thromboxane A2 was not generated by plasmin treatment at either temperature. Ultrastructural studies showed that platelets responded to low-dose plasmin at 37 degrees C by forming pseudopods, centralizing granules without fibrinogen release, whereas at 22 degrees C the same dose of plasmin caused platelet degranulation with the appearance of alpha-granule fibrinogen within the lumen of the surface connected canalicular system. In addition, at 22 degrees C plasmin at doses insufficient to induce platelet aggregation potentiated platelet response to thrombin. Thus, we suggest that plasmin may initiate both activating and inhibitory processes within platelets and that the change of temperature could influence this balance. These results may be of clinical relevance, because the fibrinolytic system was found activated during cardiopulmonary bypass in which the temperature of patient's blood circulation was reduced. This temperature-dependent behavior is also an interesting model for a further study on platelet response to serine proteinases.


Blood ◽  
1988 ◽  
Vol 72 (6) ◽  
pp. 2020-2025 ◽  
Author(s):  
WF Novotny ◽  
TJ Girard ◽  
JP Miletich ◽  
GJ Jr Broze

Abstract Stimulation with thrombin or the calcium ionophore, A23187 caused human platelets to release a coagulation inhibitor similar to the Lipoprotein Associated Coagulation Inhibitor (LACI). This was documented functionally, with clotting assays measuring tissue factor inhibition and factor Xa inhibition, as well as immunologically, in a competitive immunoassay. The total amount of LACI released by 3 x 10(8) platelets after two hours stimulation was 7% to 8% of the amount found in 1 mL of serum. Half of the LACI was released by five minutes. The LACI was present in the platelet supernatant and was not associated with the platelet membrane or shed vesicles. The tissue factor and factor Xa inhibitory activities that were released were neutralized by preincubating the platelet supernatants with specific rabbit polyclonal anti-LACI IgG. On Western blot, platelet LACI appeared to run as a doublet with a molecular weight (mol wt) 45,000 to 47,000. Blood samples obtained from the site of a wound (template bleeding time) demonstrated a progressive increase in LACI concentration. A cDNA probe, derived from endothelial cell LACI cDNA, hybridized selectively to 4.0 and 1.4 kb transcripts in a preparation of platelet mRNA.


Blood ◽  
1979 ◽  
Vol 53 (3) ◽  
pp. 437-445 ◽  
Author(s):  
DF Mosher ◽  
A Vaheri ◽  
JJ Choate ◽  
CG Gahmberg

We labeled surface glycoproteins of human platelets by the neuraminidase-galactose oxidase/borotritiide and the periodate/borotritiide methods. When labeled platelets were treated with 1-nM thrombin, a minor glycoprotein weighing 68,000–85,000-d was lost from the surface, and a soluble glycoprotein weighing 57,000- 68,000-d was found in the supernatant. Treatment of platelets with ADP, collagen, or the calcium ionophore A23187 did not cause loss of the 68,000–85,000-d glycoprotein from platelet surfaces or appearance of the 57,000–68,000-d glycoprotein in the supernatant. However, trace amounts of the intact 68,000–85,000-d glycoprotein were found in the supernatants of platelets that were not treated with thrombin. The numerous effects of thrombin on platelets could be initiated by cleavage and release the thrombin-sensitive glycoprotein.


1984 ◽  
Vol 30 (12) ◽  
pp. 2078-2083 ◽  
Author(s):  
C S Giometti ◽  
N G Anderson

Abstract Using two-dimensional electrophoresis, we mapped both the total and the cytoskeletal proteins of human platelets before and after activation with thrombin or the calcium ionophore A23187. Activation resulted in increased abundance of the phosphorylated form of myosin light chains with an approximate molecular mass of 20 kDa, decreased abundance of two proteins with molecular masses of approximately 18 and 25 kDa, and, in the case of activation with thrombin, the appearance of a new chain of protein spots (named "Thromb:1"). The latter, found associated with isolated detergent-insoluble cytoskeletons, reacted with antibody to human fibrinogen and thus were identified as gamma-gamma dimers of fibrin. The total number of proteins associated with the cytoskeleton increased after activation with either thrombin or A23187, but we observed some differences in which proteins were bound, and for how long.


Author(s):  
R. W. Tucker ◽  
N. S. More ◽  
S. Jayaraman

The mechanisms by which polypeptide growth factors Induce DNA synthesis in cultured cells is not understood, but morphological changes Induced by growth factors have been used as clues to Intracellular messengers responsible for growth stimulation. One such morphological change has been the transient disappearance of the primary cilium, a “9 + 0” cilium formed by the perinuclear centriole in interphase cells. Since calcium ionophore A23187 also produced both mitogenesis and ciliary changes, microtubule depolymerization might explain ciliary disappearance monitored by indirect immunofluorescence with anti-tubulin antibody. However, complete resorption and subsequent reformation of the primary cilium occurs at mitosis, and might also account for ciliary disappearance induced by growth factors. To settle this issue, we investigated the ultrastructure of the primary cilium using serial thin-section electron microscopy of quiescent BALB/c 3T3 cells before and after stimulation with serum.


Sign in / Sign up

Export Citation Format

Share Document